The use of an anti-IL-6 receptor (IL-6R) monoclonal antibody in RA patients with anemia has been reported previously and has provided evidence for greater improvement in Hb levels compared to the control group [17, 18]. The gene discussed is IL6R; the disease is rheumatoid arthritis.